Cargando…

Retraction Note: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout

Detalles Bibliográficos
Autores principales:	Ali, Zakir, ud Din, Fakhar, Zahid, Fatima, Sohail, Saba, Imran, Basalat, Khan, Salman, Malik, Maimoona, Zeb, Alam, Khan, Gul Majid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Retraction Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337063/ https://www.ncbi.nlm.nih.gov/pubmed/37438845 http://dx.doi.org/10.1186/s40360-023-00680-z

Ejemplares similares

Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout
por: Ali, Zakir, et al.
Publicado: (2022)

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers
por: Yu, Guo, et al.
Publicado: (2021)

Diagnostic and Treatment Strategies for COVID-19
por: Jamshaid, Humzah, et al.
Publicado: (2020)

Metformin HCl-loaded transethosomal gel; development, characterization, and antidiabetic potential evaluation in the diabetes-induced rat model
por: Nousheen, Kainat, et al.
Publicado: (2023)

Melatonin delivered in solid lipid nanoparticles ameliorated its neuroprotective effects in cerebral ischemia
por: Sohail, Saba, et al.
Publicado: (2023)

Diabetes and gout: efficacy and safety of febuxostat and allopurinol
por: Becker, M A, et al.
Publicado: (2013)

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021)

Augmented Oral Bioavailability and Prokinetic Activity of Levosulpiride Delivered in Nanostructured Lipid Carriers
por: Arif, Sadia Tabassam, et al.
Publicado: (2022)

Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis
por: Khalid, Husna, et al.
Publicado: (2022)

Nanotechnology: from In Vivo Imaging System to Controlled Drug Delivery
por: Mir, Maria, et al.
Publicado: (2017)

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
por: Jamshaid, Humzah, et al.
Publicado: (2022)

Topical Allopurinol-Loaded Nanostructured Lipid Carriers: A Novel Approach for Wound Healing Management
por: Varrica, Carla, et al.
Publicado: (2021)

Gout, flares, and allopurinol use: a population-based study
por: Proudman, Charlotte, et al.
Publicado: (2019)

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
por: Kang, Eun Ha, et al.
Publicado: (2021)

Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout
por: Eun, Yeonghee, et al.
Publicado: (2022)

Effect of nanostructured lipid carriers on transdermal delivery of tenoxicam in irradiated rats
por: Bawazeer, Saud, et al.
Publicado: (2020)

Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
por: Chauhan, Iti, et al.
Publicado: (2020)

Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
por: Din, Fakhar ud, et al.
Publicado: (2017)

Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight
por: Jamshaid, Humzah, et al.
Publicado: (2021)

Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect
por: Bashir, Sidra, et al.
Publicado: (2023)

Development of Betamethasone Dipropionate-loaded Nanostructured Lipid Carriers for Topical and Transdermal Delivery
por: Hanna, Pierre A., et al.
Publicado: (2019)

African American patients with gout: efficacy and safety of febuxostat vs allopurinol
por: Wells, Alvin F, et al.
Publicado: (2012)

Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
por: Singh, Jasvinder A., et al.
Publicado: (2017)

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
por: Guan, Xudong, et al.
Publicado: (2022)

Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell
por: Dar, M. Junaid, et al.
Publicado: (2018)

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
por: Perez-Ruiz, Fernando, et al.
Publicado: (2016)

The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout
por: Baumgartner, Scott, et al.
Publicado: (2018)

Sex differences in response to allopurinol and benzbromarone in gout: a retrospective cohort study
por: Veenstra, Frouwke, et al.
Publicado: (2021)

Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients
por: Cheng, Ching-Lan, et al.
Publicado: (2022)

Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia
por: Lai, Shih-Wei, et al.
Publicado: (2022)

Allopurinol-Induced Uncommon Dermatological Emergency of Toxic Epidermal Necrolysis (TEN)
por: Pabani, Umesh Kumar, et al.
Publicado: (2023)

Allopurinol, Benzbromarone, or a Combination in Treating Patients with Gout: Analysis of a Series of Outpatients
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2014)

Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review
por: Rezapour, Aziz, et al.
Publicado: (2020)

Febuxostat versus allopurinol for patients with gout: is it time to overcome concerns regarding cardiovascular safety?
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2021)

Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
por: Gao, Linggen, et al.
Publicado: (2021)

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
por: Pawar, Ajinkya, et al.
Publicado: (2021)

Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
por: Khan, Saba, et al.
Publicado: (2015)

Investigation of the treatment potential of Raloxifene-loaded polymeric nanoparticles in osteoporosis: In-vitro and in-vivo analyses
por: Guo, Zhonghua, et al.
Publicado: (2023)

Ethosomal Gel Formulation of Alpha Phellandrene for the Transdermal Delivery in Gout
por: Valsalan Soba, Sony, et al.
Publicado: (2021)

Gout in an Obese Patient with Nonalcoholic Steatohepatitis on a Thiazide Diuretic and Association Between Hyperuricemia and Nonalcoholic Steatohepatitis: A Case Report
por: Khan, Zahid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2p0896kqp4j4dgmunnbflnjbmb